UnitedHealth Group division calls the action “baseless” and shows “profound misunderstanding” of drug pricing.
Rossen Reports looked at the FTC data so far in 2024. Read the full story here. Millions of us have memberships to wholesale ...
The Federal Trade Commission said Friday that it is suing three drug middlemen, accusing them of inflating insulin prices.
On Friday, the Federal Trade Commission (FTC) filed a formal complaint against three major pharmacy benefit managers ...
FTC sues top PBMs for inflating insulin prices, accusing them of rigging competition and hurting patients. Legal action also includes GPOs.
The Federal Trade Commission has accused three major pharmacy benefit managers of inflating insulin prices, the agency said ...
This was the stock's second consecutive day of losses.
The Feb. 21 cyberattack on Change Healthcare crippled financial operations for hospitals, insurers, pharmacies and medical groups nationwide. In July, the organization began sending out breach ...
The FTC said CVS Caremark, Cigna’s Express Scripts, and UnitedHealth’s OptumRx profit at the expense of patients forced to ...
The ASC industry is facing two new, opposing forces: consolidation by large ASC chains and independent ASCs with non-traditional business models.
Cigna may have the edge with smaller footprint and focused approach, but all three giants face risks from FTC's lawsuit over inflated insulin prices.
The Federal Trade Commission on Friday sued prescription-drug middlemen owned by CVS Health Corp., Cigna Group and UnitedHealth Group Inc., alleging that they artificially pumped up prices of insulin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback